Your browser doesn't support javascript.
loading
Case Report: Zellweger Syndrome and Humoral Immunodeficiency: The Relevance of Newborn Screening for Primary Immunodeficiency.
Fazi, C; Lodi, L; Magi, L; Canessa, C; Giovannini, M; Pelosi, C; Pochiero, F; Procopio, E; Donati, M A; Azzari, C; Ricci, S.
Afiliação
  • Fazi C; Pediatric Immunology Division, Meyer Children's Hospital, Florence, Italy.
  • Lodi L; Pediatric Immunology Division, Meyer Children's Hospital, Florence, Italy.
  • Magi L; Department of Health Sciences, University of Florence, Florence, Italy.
  • Canessa C; Neonatology Division, San Donato Hospital, Arezzo, Italy.
  • Giovannini M; Pediatric Immunology Division, Meyer Children's Hospital, Florence, Italy.
  • Pelosi C; Pediatric Allergy Division, Meyer Children's Hospital, Florence, Italy.
  • Pochiero F; Department of Health Sciences, University of Florence, Florence, Italy.
  • Procopio E; Department of Metabolic Diseases, Meyer Children's Hospital, Florence, Italy.
  • Donati MA; Department of Metabolic Diseases, Meyer Children's Hospital, Florence, Italy.
  • Azzari C; Department of Metabolic Diseases, Meyer Children's Hospital, Florence, Italy.
  • Ricci S; Pediatric Immunology Division, Meyer Children's Hospital, Florence, Italy.
Front Pediatr ; 10: 852943, 2022.
Article em En | MEDLINE | ID: mdl-35402347
ABSTRACT

Background:

Zellweger syndrome (ZS) is a congenital autosomal recessive disease within the spectrum of peroxisome biogenesis disorders, characterized by the impairment of peroxisome assembly. The presence of peroxisome enzyme deficiencies leads to complex developmental sequelae, progressive disabilities, and multiorgan damage, due to intracellular accumulation of very-long-chain fatty acids (VLCFAs). Case Presentation We report the case of an infant affected by ZS in which agammaglobulinemia, detected through neonatal screening of congenital immunodeficiencies, appeared as a peculiar trait standing out among all the other classical characteristics of the syndrome. The exome analysis through next-generation sequencing (NGS), which had previously confirmed the diagnostic suspicion of ZS, was repeated, but no mutations causative of inborn error of immunity (humoral defect) were detected.

Conclusion:

In this case, no genetic variants accountable for the abovementioned agammaglobulinemia were detected. Given that the scientific literature reports the involvement of peroxisomes in the activation of Nuclear Factor κ-light-chain-enhancer of activated B cells (NF-κB) pathway, which is crucial for B-cell survival, with this work, we hypothesize the existence of a link between ZS and humoral immunodeficiencies. Further studies are required to confirm this hypothesis.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article